| Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis (NCT00277394) | LEO Pharma | 2005-12-01 |
| Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study (NCT00252005) | Bristol-Myers Squibb | 2005-11-01 |
| Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients (NCT00333697) | Intermountain Health Care, Inc. | 2005-11-01 |
| Odiparcil For The Prevention Of Venous Thromboembolism (NCT00244725) | GlaxoSmithKline | 2005-09-01 |
| Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot (NCT00114608) | University at Buffalo | 2005-06-01 |
| Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis (NCT00123734) | Agen Biomedical | 2005-03-01 |
| Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (NCT00450645) | Azienda Ospedaliera Universitaria Policlinico | 2005-03-01 |
| Improving Lower Limb Blood Flow in Healthy Adult Volunteers (NCT01981733) | Queen Mary University of London | 2005-03-01 |
| Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT) (NCT00157677) | McMaster University | 2004-10-01 |
| The 36-month Extension to Follow up Sub Study (NCT01615692) | Sir Mortimer B. Davis - Jewish General Hospital | 2004-06-01 |
| Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT) (NCT00839163) | Bayer | 2004-03-01 |
| Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) (NCT00067093) | Sanofi | 2003-05-01 |
| Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study (NCT00655122) | Pfizer | 2003-04-01 |
| Understanding Risk Factors Involved in Developing a Second Blood Clot. (NCT00261014) | Ottawa Hospital Research Institute | 2002-10-01 |
| Treatment of Upper Extremity Deep-Vein Thrombosis (NCT00245856) | University of Oklahoma | 2002-09-01 |
| D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism (NCT00264277) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2002-09-01 |
| The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial (NCT00187408) | Sunnybrook Health Sciences Centre | 2002-08-01 |
| The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section (NCT00225108) | Ottawa Hospital Research Institute | 2002-07-01 |
| MDA D-Dimer / Recurrent DVT Study (NCT00157599) | McMaster University | 2002-01-01 |
| Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients (NCT00041782) | M.D. Anderson Cancer Center | 2000-10-01 |
| Venous Thromboembolism in DM1 (NCT03141749) | Institut de Myologie, France | 2000-01-01 |
| 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE (NCT00365950) | British Thoracic Society | 1999-09-01 |
| Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants (NCT00623987) | Azienda Ospedaliera Universitaria Policlinico | 1999-06-01 |
| Ultrasound Findings to Adjust the Duration of Anticoagulation (NCT00380120) | University of Padova | 1999-01-01 |
| D-Dimer and IPG for Recurrent Thrombosis (DIRECT) (NCT00182247) | Hamilton Health Sciences Corporation | 1998-12-01 |
| Fixed Dose Heparin Study (NCT00182403) | McMaster University | 1998-09-01 |
| VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis (NCT00314990) | Radboud University Medical Center | 1996-01-01 |
| Personalized Medicine Decision-Making in a Virtual Clinical Setting (NCT02108041) | National Human Genome Research Institute (NHGRI) | |